[Federal Register Volume 78, Number 39 (Wednesday, February 27, 2013)]
[Notices]
[Pages 13344-13345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-04508]



[[Page 13344]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-13-0852]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to [email protected]. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    Prevalence Survey of Healthcare-Associated Infections (HAIs) in 
Acute Care Hospitals in the United States--Extension--(0920-0852 exp.5/
31/13)--National Center for Emerging and Zoonotic Infectious Diseases, 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Preventing healthcare-associated infections (HAIs) is a CDC 
priority. An essential step in reducing the occurrence of HAIs is to 
estimate accurately the burden of these infections in U.S. hospitals, 
and to describe the types of HAIs and causative organisms. The scope 
and magnitude of HAIs in the United States were last directly estimated 
in the 1970s by CDC's Study on the Efficacy of Nosocomial Infection 
Control (SENIC), in which comprehensive data were collected from a 
sample of 338 hospitals; 5% of hospitalized patients acquired an 
infection not present at the time of admission. Because of the 
substantial resources necessary to conduct hospital-wide surveillance 
in an ongoing manner, most of the more than 4,500 hospitals now 
reporting to the CDC's current HAI surveillance system, the National 
Healthcare Safety Network (NHSN 0920-0666 expires 1/31/15), focus 
instead on device-associated and procedure-associated infections in a 
selected patient locations, and do not report data on all types of HAIs 
occurring hospital-wide. Periodic assessments of the magnitude and 
types of HAIs occurring in all patient populations within acute care 
hospitals are needed to inform decisions by local and national policy 
makers and by hospital infection control personnel regarding 
appropriate targets and strategies for HAI prevention. Such assessments 
can be obtained in periodic national prevalence surveys, such as those 
that have been conducted in several European countries.
    In 2008-2009, CDC developed a pilot protocol for a HAI point 
prevalence survey, conducted over a 1-day period at each of 9 acute 
care hospitals in one U.S. city. This pilot phase was followed in 2010 
by a phase 2, limited roll-out HAI and antimicrobial use prevalence 
survey, conducted during July and August in 22 hospitals across 10 
Emerging Infections Program sites (in California, Colorado, 
Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, 
Oregon, and Tennessee). Experience gained in the phase 1 and phase 2 
surveys was used to conduct a full-scale, phase 3 survey in 2011, 
involving 183 hospitals in the 10 EIP sites. Over 11,000 patients were 
surveyed, and analysis of HAI and antimicrobial use data is ongoing at 
this time. Preliminary HAI prevalence results were presented at the 
52nd Interscience Conference on Antimicrobial Agents and Chemotherapy 
(San Francisco, CA, September 8-12, 2012) and preliminary antimicrobial 
use results were presented at the 2012 IDWeek conference (San Diego, 
CA, October 17-21, 2012).
    An extension of the prevalence survey's existing OMB approval is 
sought, to allow a repeat HAI and antimicrobial use prevalence survey 
to be performed in 2014. A repeat survey will allow further refinement 
of survey methodology and assessment of changes over time in 
prevalence, HAI distribution, and pathogen distribution. It will also 
allow for a re-assessment of the burden of antimicrobial use, at a time 
when antimicrobial stewardship is an area of active engagement in many 
acute care hospitals. The 2014 survey will be performed in a sample of 
up to 500 acute care hospitals, drawn from the acute care hospital 
populations in each of the 10 EIP sites (and including participation 
from many hospitals that participated in prior phases of the survey). 
Infection prevention personnel in participating hospitals and EIP site 
personnel will collect demographic and clinical data from the medical 
records of a sample of eligible patients in their hospitals on a single 
day in 2014, to identify CDC-defined HAIs. The surveys will provide 
data for CDC to make estimates of the prevalence of HAIs across this 
sample of U.S. hospitals as well as the distribution of infection types 
and causative organisms. These data can be used to work toward reducing 
and eliminating healthcare-associated infections--a DHHS Healthy People 
2020 objective (http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=17). This survey project also supports the CDC 
Winnable Battle goal of improving national surveillance for healthcare-
associated infections (http://www.cdc.gov/winnablebattles/Goals.html).
    The total burden is 9,375 hours, which represents an increase of 
250 hours over the previously approved burden. The increase is 
requested because the median number of responses per respondent in the 
2011 phase 3 survey was 75. Previously, we had estimated 73 responses 
per respondent. There are no costs to respondents. The total estimated 
annualized burden is 9,375.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of     Average  burden
                         Respondents                              Number of      responses per    per  response
                                                                 respondents       respondent        in hours
----------------------------------------------------------------------------------------------------------------
Infection Prevention Personnel in Participating Hospitals....             500               75            15/60
----------------------------------------------------------------------------------------------------------------


[[Page 13345]]

    *Assumptions: One respondent per hospital, collection of data on 
median of 75 patients per hospital, average data collection time of 15 
minutes per patient.

Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity, Office of the 
Associate Director for Science, Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-04508 Filed 2-26-13; 8:45 am]
BILLING CODE 4163-18-P